# Phase 1 BIO 300 Oral Suspension

> **NCT06741345** · PHASE1 · COMPLETED · sponsor: **Humanetics Corporation** · enrollment: 56 (actual)

## Conditions studied

- Healthy Volunteer Study

## Interventions

- **DRUG:** BIO 300 Oral Suspension

## Key facts

- **NCT ID:** NCT06741345
- **Lead sponsor:** Humanetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-23
- **Primary completion:** 2025-08-15
- **Final completion:** 2025-08-15
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06741345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06741345, "Phase 1 BIO 300 Oral Suspension". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06741345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*